Behçet’s Syndrome: where do we stand?
- 1 January 2002
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 112 (1) , 75-76
- https://doi.org/10.1016/s0002-9343(01)01081-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Vascular involvement in Behçet’s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulinThe American Journal of Medicine, 2002
- A double-blind trial of colchicine in Beh et's syndromeArthritis & Rheumatism, 2001
- Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51Annals of the Rheumatic Diseases, 2001
- Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked studyAnnals of the Rheumatic Diseases, 2001
- Clinicopathologic Evaluation of Nodular Cutaneous Lesions of Behçet SyndromeAmerican Journal of Clinical Pathology, 2001
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patientsBrain, 1999
- Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet SyndromeAnnals of Internal Medicine, 1998
- Surgical therapy of pulmonary arterial aneurysms in Behçet's syndromeThe Annals of Thoracic Surgery, 1996